Table 5.
Reference | Study population (n) | Prevalence of anti-HCV positive (%) | Prevalence of HCV RNA positive (%) |
---|---|---|---|
North Vietnam | |||
Hoang TL et al. [10] | Rural population (1563) | 0.38 | |
Hoang DM [6] | Urban, rural population and islanders (975) | 1.3 | |
Hoang DM [6] | Blood donors (120) | 7.5 | |
Pham S et al. [7] | Blood donors (499) | 0.8 | |
Nakata S et al. [8] | Patients without liver diseases (511) | 4.0 | |
Corwin AL et al. [13] | Patients without liver diseases (187) | 1.0 | |
Hoang DM et al. [6] | Patients with liver diseases (262) | 17.9 | |
Vu VK et al. [15] | Patients with liver diseases (154) | 14.3 | |
Nguyen TV et al. [14] | Patients with liver diseases (76) | 9.2 | |
Corwin AL et al. [13] | Patients with liver diseases (188) | 10.0 | |
Hoang DM [6] | IDUs (50) | 72.0 | |
Nakata S et al. [8] | IDUs (200) | 31.0 | |
Central and Southern Vietnam | |||
Kakumu S et al. [12] | Central rural population (890) | 1.0 | |
La TN [9] | Government employees, students, workers, urban population (2573) | 4.31 | |
Tran HTT et al. [11] | Southern urban population (100) | 2.0 | |
Pham S et al. [7] | Blood donors (491) | 20.6 | |
Nakata S et al. [8] | Patients without liver diseases (491) | 9.0 | |
Tran HTT et al. [11] | Patients with liver diseases (234) | 19.2 | |
Kakumu SK et al. [12] | Patients with liver diseases (289) | 23.1 | |
La TN [9] | IDUs (108) | 97.22 | |
Nakata S et al. [8] | IDUs (67) | 87.0 |
Abbreviation: IDUs, injecting drug users